Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals

ABSTRACT

Systems, methods, and apparatuses monitor mammal conditions, report condition changes, and provide neurocode-based treatment in response to condition changes. A mammal implantable controller includes modules to monitor, wirelessly communicate to external computers, and administer treatment received from a remote computer based on monitoring of changes in mammal condition as analyzed by the remote computer. External computers can be provided in the form of a mobile device (e.g., smartphone/tablet), resident treatment pods, and treatment servers. Treatment can be provided to change biological function or trigger cell death in cancer cells.

INVENTION PRIORITY

The embodiments described herein are being filed as a continuationapplication of U.S. Provisional Patent Application Ser. No. 62/202,286,filed Aug. 7, 2015, entitled “Systems, Methods and Apparatuses forProviding Bioelectronic Neurocode-based Therapies to Mammals”, which isherein incorporated by reference in its entirety.

TECHNICAL FIELD

Embodiments generally relate to the field of bioelectronic medicine or“electroceuticals.” Embodiments further relate to systems, methods, andapparatuses for the monitoring and the alteration of conditions inmammals using neurological signal coded (“Neuro-code” or “Neurocode”)therapies. Embodiments additionally relate to systems, methods, andapparatuses for inducing apoptosis (programmed cell death) in cancercells due to reprogramming the intra-cellular operational communicationnetwork.

BACKGROUND OF THE INVENTION

Every biological process is also an electrical process. Cells haveelectrical capabilities and can communicate with each adjacent cell.Normal cells have electro-chemical aspects to manage and operate theintracellular biological mechanisms to control metabolism, reproduction,and cell defense. Not all cells provide a benefit to the human body.Cancer cells, for example, seek to take over normal cells bio-machineryand eventfully destroy them through their communication network. Allcell activity is based on communication of low voltage frequencysignals, which will be referred to herein as “neurocodes”.

The discovery and study of neurological signals (Neurocodes) started in1780 when Luigi Galvani, an Italian anatomist, attached two dissimilarwires to the spine of a large decapitated frog. Galvani passed a currentinto the frog by means of a static-electrically-charge rod and made theanimal's legs jerk. He determined that nerves conducted electricity andat that moment launched the science of neurophysiology. Galvani'sfriend, Alessandro Volta, the inventor of the wet-cell battery,commented in 1800 that it was the electrical stimulation from thebi-metal wires which provided the energy to make the frog's legs kick.Thus began the use of stimulating currents to induce neurons to firetheir signals, which continues in research universities to this veryday.

It never occurred to anyone in those early years that the nerves wereactually capable of generating signals on their own without therequirement for some sort of electrical stimulation. It is important torealize that there was no possible way to visualize the cells untilafter the microscope was invented by Zacharias Jansen in 1590. It wasn'tuntil later in the 1600's that Antony van Leeuwenhoek improved upon thatinvention and was able to peer at what he called “animalcules.” WhatLeeuwenhock saw were microbes, which was previously unrealized byanyone. He mentioned that there had to be some connection between whathe saw and diseases. Early microscopes were not used to study cellularor nervous system structure.

The microscope became more prevalent throughout most universitylaboratories by 1830 where many biologists began to explore the makeupof life. In Berlin around 1840, Theodor Schwann and Jacob Schleidenestablished that discrete cells were indeed the architectural buildingblocks of living tissue, be they plant or animal. This discovery pavedthe way for others to think about the individual function of manydifferent kinds of cells. Previously, in 1836, Jan Purkinje, a Czechhistology and physiologist and his student Gabriel Valentine were ableto claim, “The entire nervous system is made up of globules (cells) andcontinuous primitive fibers (axons).” In 1837, Purkinje was able todescribe brain cells with their nuclei and dendrites and the flask-likecells named “Purkinje cells,” which are efferent types.

By 1870, very few scientists knew what a neuron really was, much lesswhat it looked like, or how it worked. Therefore, it was stillimpossible to describe a three-dimensional nervous system at that timein history. But this was to change around 1877 when Camillo Golgi ofItaly was able to silver-stain individual neurons so they could bestudied under the microscope. Using Golgi's stain, a Spanish professorwas able to begin an exhaustive study of the details of neuronalanatomy. Santiago Ramon y Cajal had proposed that neurons were thesignaling units for the entire nervous system. This is often referred toas the beginning of the “neuron doctrine.” From 1879, Cajal exhaustivelystudied the brain and many of its structures as he enlarged hisunderstanding of the nervous system. Cajal published numerous technicalpapers to begin his explanation of the anatomical structure of nervesand the brain. Cajal became recognized throughout Europe by 1889 for hisimportant work. As a result, both Golgi and Cajal shared the Nobelprized in physiology and medicine in 1906.

It was not until the late 20^(th) and early 21^(st) centuries that truebioelectronic medical treatment approaches involving the use ofneuro-coded or electrical signaling technologies were possible. Morerecent advances in technology have allowed for the development ofbioelectronic approaches to treating a variety of conditions, includingcancer. True bioelectronic medical treatment applications are nowpossible given advancements in electronics and a better understand ofhow conditions such as cancer actually function in the human body.

One of the present inventors, Eleanor Schuler, has been heavily involvedin the development of the premier bioelectronic technology of our timeas outlined in a variety of bioelectronic medical treatment patents andpatent applications covering the use of neuro-coded signalingtechnology. Many patents have already been issued to her for thistechnology. Schulers intellectual property portfolio implementsclosed-loop neuromodulation systems that can utilize innateneurophysiological circuits to achieve therapeutic benefits (e.g.,“Electrical Prescriptions” as recently referred to by the DefenseAdvanced Research Projects Agency, DARPA) in a number of medical areas.Examples of only a few of Schuler's patents, which are hereinincorporated by reference for their teaching and provide amplebackground for the science, include: U.S. Pat. No. 8,781,593, entitled“System and Method for Controlling Skeletal Muscles by Means ofNeuro-electrical Coded Signals”; U.S. Pat. No. 8,725,246, entitled“Method and System for Modulating Eating Behavior by Means ofNeuro-Electrical Coded Signals”; U.S. Pat. No. 8,509,887, entitled“Method to Record, Store and Broadcast Specific Brain Waveforms toModulate Body Organ Functioning”; U.S. Pat. No. 8,818,502, entitled“Method and System for Regulation of Endocrine and Exocrine Glands byMeans of Neuro-Electrical Coded Signals”, U.S. Pat. No. 6,957,106,entitled “Implantable Method to Regulate Blood Pressure by Means ofCoded Nerve Signals”, U.S. Pat. No. 6,751,501, entitled “Method andApparatus for Myocardial Control”, U.S. Pat. No. 6,633,779, entitled“Treatment of Asthma and Respiratory Disease by Means of ElectricalNeuro-Receptive Waveforms”, and U.S. Pat. No. 6,775,573, entitled“Electrical Method to Control Autonomic Nerve Stimulation ofGastrointestinal Tract”.

Further validation of Schuler's bioelectronic technology is evidence bythe fact that large pharmaceutical companies and organizations are nowmoving into the field of bioelectronics, albeit many years after theSchuler's initial patent application filings, and without much in theway of intellectual property. For example, the monolithic internationalpharmaceutical giant GSK (GlaxoSmithKline) announced in 2013 that it waspursuing an effort toward the development of “electroceutical” orbioelectronic medicine (see “A Jumpstart-Start for Electroceuticals,Nature”, 11 Apr. 2013, Vol 496, pp. 159-161, Famm et al). EleanorSchuler's own research and thinking in the bioelectronic area wascaptured in patent filings by her many years prior to GSKs 2013initiative.

To date, the primary approach to treating cancer based on bioelectronictechnology has been outlined in further patents and patent applicationpublications by Eleanor Schuler. Such approaches are disclosed in, forexample, U.S. Patent Application Publication No. 2010/0286689 entitled“Method and System for Processing Cancer Cell Electrical Signals forMedical Therapy,” which published on Nov. 11, 2010; U.S. PatentApplication Publication No. 2011/0270248 entitled “System and Method toElicit Apoptosis in Malignant Tumor Cells for Medical Treatment,” whichpublished on Nov. 3, 2011; U.S. Patent Application Publication No.2011/0130754 entitled “Hybrid Scientific Computer System for ProcessingCancer Cell Signals as Medical Therapy,” which published on Jun. 2,2011; and U.S. patent application Ser. No. 12/334,212 entitled “Methodto Switch-Off Cancer Cell Electrical Communication Codes as MedicalTherapy,” which was filed on Dec. 12, 2008. U.S. Patent ApplicationPublication Nos. 2010/0286689; 2011/0270248; and 2011/0180754; and U.S.patent application Ser. No. 12/334,212 are incorporated herein byreference in their entireties. Additionally, Provisional PatentApplication Ser. No. 61/940,054 entitled “Encoded Bioelectronic Methodand System and Calcium Treatment for Slaying Cancer by Rapid Triggeringof Cellular Apoptosis and Karyorrhexis,” which was filed on Feb. 14,2014. All these patents and publications are also incorporated herein byreference in their entirety for their teaching.

What is needed now in light of Schuler's extensive bioelectronicmedicine portfolio is improved systems, methods, and apparatuses forproviding these electroceutical therapies to mammals. Inventors in thewireless data communications field, Luis Ortiz and Kermit Lopez, havejoined with Eleanor Schuler to address the stated need. Messrs. Ortizand Lopez are the co-inventors of numerous mobile wireless technologiesand applications dating back to the year 2000, including U.S. Pat. No.9,031,537, which is entitled “Electronic Wireless Hand Held MultimediaDevice”, which is also incorporated herein by reference for its teachingof hardware, systems, and processes associated with mobile datacommunications. Together, the present inventors provide systems,methods, and apparatuses for providing bioelectronics therapy to mammals(e.g., humans, pets, livestock, etc.), which will be further describedin the detailed specification that follows.

BRIEF SUMMARY

The following summary is provided to facilitate an understanding of someof the innovative features unique to the disclosed embodiments and isnot intended to be a full description. A full appreciation of thevarious aspects of the embodiments disclosed herein can be gained bytaking the entire specification claims, drawings, and abstract as awhole.

It is, therefore, one aspect of the disclosed embodiments to provide forimproved systems, methods, and apparatuses for monitoring bioelectronicneurocode-based) signals associated with organ function in mammals andproviding bioelectronic therapy to mammals based on monitoredconditions.

It is yet another aspect of the disclosed embodiments to provide forimproved systems, methods, and apparatuses for treating cancer. Thetreatment time for causing apoptosis, excitotoxicity, or osmotic-shockto cancer cells and/or malignant tumors can be from as little as lessthan 20 minutes, and up to many hours, depending on the size andlocation of the target tumor. The procedure described can also beutilized to treat malignant tumors as well as benign tumors such asuterine fibroid or muscle and limb tumors.

It is another aspect of the present invention that a system can includea wireless computing device that can be in wireless communication withat least one mammal implantable controller (“NC”) that includes wirelessmodule supporting communications in close proximity with the wirelesscomputing device. It is also a feature that the wireless computingdevice can be provided in the form of a mobile device (e.g., in formfactor of a smartphone, tablet) serving as a treatment computer.

It is yet another feature of the present invention that the handheldcomputer has a processor and memory and can record signals monitored bythe at least one mammal implantable controller and provided feedback inthe form of bioelectronic signals (neurocodes) via the wireless moduleassociated with the at least one mammal implantable controller.

It is yet another feature of the present invention that bioelectronicsignals can be provided by either wired or wireless communication to anorgan in response to monitoring. Wired communication of bioelectronicsignals can be provided via a probe connectable by wire to the mobiledevice that can enter a mammal's body and contact a targeted organ orregion for the administration of bioelectronic therapy. Wirelesscommunication of bioelectronic signals can be provided to an organ viacommunication with at least one mammal implantable controller that canbe further connected (e.g., via internal probe connection) to the organor region in order to receive the neurocodes wirelessly from thewireless device located a short distance outside the mammal.

In yet another embodiment, bioelectronics signals can be obtained by amobile device (e.g., a smartphone or tablet supporting secure wirelesscommunications with remote resources via Wi-Fi or cellularcommunications) from a remote treatment server via a data communicationsnetwork based on a monitored condition. The monitored condition can bemonitored in real-time in accordance with features of the presentinvention or via traditional monitoring means (e.g., recordation ofvitals), and can be communicated to the remote server securely over thedata communications network via the mobile device.

It is yet another feature of the present invention that a remotetreatment server can provide neurocodes to MICs via either mobiledevices or facility installed treatment pods having short range wirelesscapabilities to communicate with MICs, and the ability to communicatewith a remote treatment server or mobile device either wirelessly or viawired data connection.

It is yet another feature of the present invention for more than onetreatment pod to be installed in a facility in a manner to providemonitoring and communications with MICs that may be implanted in morethan one mammal (e.g., several patients in a treatment facility orhospital).

It is yet another embodiment, mammal implantable controllers (“MICs”)can be implantable in a mammal and support radio frequency (RF)communication with a mobile device or other monitoring devices(stationary monitoring pods installed in treatment facilities). A MICcan include a wireless module supporting secure communications in closeproximity with the monitoring device (mobile device or pod). It is alsoa feature that the MIC can be recharged electromagnetically whileimplanted in a mammal, thereby avoiding openings in the skin of amammal's body for connection or wiring. A MIC can also includemonitoring capabilities via a monitoring module adapted for targetedmonitoring of a certain conditions (e.g., insulin, heart rate, bloodoxygen), and can provide bioelectronic signals to target organs orregions in the mammal via an associated or integrated neurocode module.Probes can connect a MIC and a target organ or region and also remainimplantable within the mammal.

These and other features and embodiments of the present invention willbecome apparent to the skilled after reading the following detaileddescription and the appended claims.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying figures, in which like reference numerals refer toidentical or functionally-similar elements throughout the separate viewsand which are incorporated in and form a part of the specification,further illustrate the embodiments and, together with the detaileddescription, serve to explain the principles of the present invention.

FIGS. 1(a), 1(b) and 1(c), labeled as prior art, illustrates a pictorialdrawing of a mobile device;

FIG. 2, labeled as prior art, illustrates a pictorial representation amobile device, and which can be implemented in accordance with analternative embodiment;

FIG. 3, labeled as prior art, illustrates another pictorialrepresentation of a mobile device including a removable cartridge;

FIG. 4, labeled as prior art, illustrates a block diagram of a desktopcomputer including neurocode functionality;

FIG. 5, labeled as prior a illustrates an imulus for deliveringtreatment to cells;

FIG. 6 illustrates a block diagram of a mobile device similar to thatillustrated and described with respect to FIGS. 1-3, but including aneurocode module therein;

FIG. 7 illustrates a block diagram of a mammal implantable controller(MIC);

FIG. 8 illustrates a functional diagram of a mobile device such as thatin FIG. 6 in short-range wireless communication with at least one mammalimplanted controller such as presented in FIG. 7;

FIG. 9 illustrates a functional diagram of a mobile device incommunication with a remote neurocode treatment server via a datacommunication network;

FIG. 10 illustrates a functional diagram of the mobile device of FIG. 6in communication with a remote server (e.g., neurocode treatment server)via a data communication network, and also in communication with amammal implanted controller; and

FIGS. 11-14 illustrate flow diagrams for methods of monitoring andproviding neurocode based bioelectronic therapy to mammal in accordancewith the teachings of the present contained herein.

DETAILED DESCRIPTION

The particular values and configurations discussed in these non-limitingexamples can be varied and are cited merely to illustrate at least oneembodiment and are not intended to limit the scope thereof.

The disclosed embodiments generally cover a number of varyingembodiments including, for example, systems and methods used forenabling bodily/organ function, or the rapid destruction of malignanttumors by excitotoxicity osmotic-shock medical tactics. Particulartreatments are described in the patent documents by Eleanor Schuler,which have been identified in the Background and are incorporated byreference for their teaching. It should be appreciated that the systemsand methods described herein can generally apply to monitoring of anybodily functions and the application of any therapies that may bedeveloped and apply to all mammals. For example, it is envisaged thatthe present invention can be used to apply bioelectronics therapies tocattle for promoting development of a cattle heard, and to race horsesto encourage or affect muscular development.

Electronic wireless hand held devices (“mobile devices”), such asdata/video-enabled cellular telephones (often referred to as “mobilephones” or “smartphones”), tablet computers, and other portable handheld wireless data-enabled devices have become a part of everyday life.Such mobile device are capable of multimedia data transmission andretrieval from multiple networks and wireless connections including:cellular (including 4G/LTE), 802.11 WiFi networks, short range radiofrequency, and/or line of sight communications standards and networkssuch those that are standardized including Bluetooth, Bluetooth LE, IrDA(infrared), RFID, NFC, and other proprietary secure means that are notyet standardized. Many current mobile devices are capable of determininglocation information and directions using GPS and by displaying mapsretrieved from remote servers (e.g., via the Internet), include touchsensitive display screens, and incorporate high-resolution cameras.Mobile devices are capable of moving data to/from, and operating with,removable cartridges (e.g., external memory, smart card, card-basedapplication modules and electronics) and/or via wireless communicationto neighboring devices U.S. Pat. No. 9,031,537, which has beenincorporated by reference, is an example of an existing mobile device.

Unlike personal computers, which are general-purpose devices gearedtowards refining and processing information, modern mobile communicationdevices are designed to capture, store, and display informationoriginating from various sources while a user is “on the go” orotherwise mobile. Additionally, while a certain level of skill isrequired to use a personal computer effectively, mobile devices aredesigned with the novice and non-computer user in mind and are thereforeintuitively easy to use. A typical smartphone or tablet includes amicroprocessor, memory unit, a display, associated encoder circuitry,and a user interface generally provided in the form of a keyboard andselector buttons. Many mobile devices in the form of smartphones andtablets can optionally contain an infrared emitter and wirelessreceiver. A graphical user interface permits a user to store, retrieve,and manipulate data via an interactive touch-sensitive display. A mobiledevice can also include software that enables software applications forusing a calendar, directory, calculator, games, and one or moremultimedia programs. The calendar typically provides dates organized asrows and columns in the usual form. A directory contains entriesconsisting of a name field and a free form alphanumeric text field thatcan contain company names, addresses, telephone and fax numbers, emailaddresses, etc. Games and multimedia software features can vary.

A menu of icons displayed via the graphical user interface as part ofthe touch sensitive screen can permit a user to choose particularfunctions and directories. Some mobile devices come equipped with astylus, which is a plastic-tipped pen that a user utilizes to writedigitally on the display area and tap particular graphically displayedicons; although a user's figure nail can accomplish the same. Each iconis indicative of a particular activity or function. Touch screeninterfaces, however, are also increasingly being implemented with mobiledevices to permit a user to activate software modules in the form ofroutines and subroutines operable therein.

Referring to FIG. 1(a), which has been labeled as prior art, a pictorialrepresentation is presented of a mobile device 11, which can beimplemented in accordance with a preferred embodiment. The mobile deviceis shown in a familiar “smartphone” form factor. Data can be transferredto and from the mobile device 11 via wireless data communications. Notethat as utilized herein, the term “data” as utilized herein generallyrefers to signals that can be presented in the form of text, voice,graphics, and/or video, but can include other types of data such assoftware, security codes, encryption, decryption, etc. Such data caninclude, for example, “multimedia data” such as video, voice audio, etc.

In general, the mobile device 11 can include a touch sensitive displayscreen 18, a speaker 30, a microphone 31, and one or more controlbuttons 32 for controlling some operations of device 11. The device 11depicted in FIG. 1(a) can be a device, such as, for example, asmartphone capable of communicating with a wireless local area network,and so forth. In this respect, the mobile device 11 can be implementedwith touch screen capabilities associated with the display screen 18.Display screen 18 can be configured to display data including video andtext and icons 33 operable as soft buttons providing options and actionby the mobile device 11 when selected by a user.

FIG. 1(b), labeled as prior art, depicts a schematic diagramillustrating a general hardware configuration of a mobile device 11which can be implemented in accordance with an embodiment. The diagramdepicted in FIG. 1(b) illustrates a variety of hardware configurationsand components/modules, which can be utilized to implement one possibleembodiment of the mobile device 11. Those skilled in the art canappreciate, however, that other hardware configurations with less ormore hardware and/or modules can be utilized in carrying out the mobiledevice 11 of the present invention, as will be further described herein.

The mobile device 11 can be capable of carrying out a variety offunctionalities. For example, microprocessor shown as CPU 10 of themobile device 11 can function as a main controller operating under thecontrol of operating clocks supplied from a clock oscillator. CPU 10 canbe configured as, for example, a microprocessor. Such a microprocessorcan be configured to facilitate operation of and communicate by theelectronic wireless hand held multimedia device 11. External pins of CPU10 can be coupled to an internal bus 26 so that it can be interconnectedto respective components.

The mobile device 11 can also be configured to include memories such as,for example, SRAM 24 which can be provided as a writeable memory thatdoes not require a refresh operation and can be generally utilized as aworking area of CPU 10, SRAM (Static RAM) is generally a form ofsemiconductor memory (RAM) based on a logic circuit known as aflip-flop, which retains information as long as there is enough power torun the device. Font ROM 22 can be configured as a read only memory forstoring character images (e.g., icons and font) displayable on a display18, which can be implemented as, for example, a touch sensitive displayscreen. Example types of displays that can be utilized in accordancewith display 18 include, for example, a TFT active matrix display, anilluminated LCD (Liquid Crystal Display), or other small-scaled displaysbeing developed or available in the art in compact form.

CPU 10 can be utilized to drive display 18 utilizing, among other media,font images from Font ROM 22 and images transmitted as data throughwireless unit 17 and processed by image-processing unit 35. EPROM 20 canbe configured as a read only memory that is generally erasable undercertain conditions and can be utilized for permanently storing controlcodes for operating respective hardware components and security data,such as a serial number. A camera capable of capturing video andpictures can be provided and can also work in conjunction with imageprocessing unit 35.

IR controller 14 when provided can be generally configured as adedicated controller for processing infrared codes transmitted/receivedby an IR transceiver module 16 and for capturing the same as computerdata. Wireless unit 17 can be generally configured as a dedicatedcontroller and transceiver module for processing all wireless datatransmitted from and to a wireless communications network, such aswireless communication network 152, which is described in greater detailherein, but not shown in FIG. 1(b).

Note that the radio frequency (RF) wireless transceiver modules 17(i.e., transceiver module) can constitute more than one wirelesstransceiver (e.g., multiple transceivers) or a wireless module withmultiple transceivers capability and formed separately or combined on anASIC or DSP circuit. For example, FIG. 1(c), labeled as prior art,illustrates a block diagram of RF wireless transceiver modules 17configured for use with the electronic wireless hand held multimediadevice 11, in accordance with an alternative embodiment, including, forexample, a first transceiver module 17 a, a second transceiver module 17b, a third transceiver module 17 c, a fourth transceiver module 17 d,and up to an “n^(th)” transceiver module, and so on.

The first wireless transceiver module 17 a can be configured, forexample, to support hi-directional data communications of the mobiledevice 11 with remote data resources (e.g., servers) over cellular datatelecommunications networks. Wireless unit/transceiver module 17 canalso include the second wireless transceiver module 17 b configured tosupport bi-directional data communications of the mobile device 11 withremote data resources over a wireless local area network (e.g.,80211/Wifi). Additionally, wireless transceiver module 17 can includethe third wireless transceiver module 17 c configured to supportbi-directional data communications of the mobile device 11 over a directwireless connection with electronic devices located at short range thatcan be established, for example, within up to five feet, or within x toa hundred foot range from the mobile device 11. Additionally, wirelessunit/transceiver module 17 can include the fourth wireless transceivermodule 17 d configured to support hi-directional data communications ofthe mobile device 11 over an infrared wireless connection withelectronic devices located at line of sight (or “visible”) range, whichcan reasonably be within up to a fifty foot range from the electronicwireless hand held multimedia device 11. It can be appreciated thatother variations for wireless transceiver module 17 can also beprovided, such as standardized Bluetooth, NFC, Zigbee, etc., andproprietary RF protocols that may be developed for specializedapplications.

Referring back to FIG. 1(b), port 12 can be connected to CPU 10 and canbe temporarily attached, for example, to a docking station to transmitinformation to and from the mobile device 11 to other devices, such aspersonal computers, points of sale such as retail cash registers,electronic kiosk devices, and so forth. In light of the presentinvention, port 12 can also be connected to external probes and externalsensors for monitoring or providing data. Port 12 can also beconfigured, for example to link with a modem, cradle, or dockingstation, which is well known in the art, and can permit network devices,a personal computer, or other computing devices to communicate withmobile device 11.

User controls 32 can permit a user to enter data to mobile device 11and/or initiate particular processing operations via CPU 10. A userinterface 33 can be linked to user controls 32 to permit a user toaccess and manipulate electronic wireless hand held multimedia device 11for a particular purpose, such as, for example, viewing video images ondisplay 18. Those skilled in the art will appreciate that user interface33 can be implemented as a touch screen manipulated user interface, asindicated by the dashed lines linking display 18 with user interface 33.User interface 33 can be configured to accept user input into the mobiledevice 11. In addition, CPU 10 can cause a sound generator 28 togenerate sounds of predetermined frequencies from a speaker 30. Speaker30 can be utilized to produce music and other audio informationassociated with video data transmitted to mobile device 11 from anoutside source.

Additionally, a GPS (Global Positioning System) module 13 can beincluded in the mobile device and can be connected to bus 26. GPS module13 can be configured to provide location information for the mobiledevice 11 and can operate with mapping software and resources to providenavigable directions on the display screen 18 to the user, which can bereferred to as GPS mapping.

Those skilled in the art can appreciate that additional electroniccircuits or the like other than, or in addition to, those illustrated inFIG. 1 can be required to construct mobile device 11. Mobile devices canbe modified to (e.g., with proper authentication, filters, securitycodes, biometrics or the like) to receive RF transmissions from at leastone source (e.g., remote server, a wireless camera, or data from acamera transmitted wirelessly through a local data transmitter usingWi-Fi). Those skilled in the art can thus appreciate that because of thebrevity of the drawings described herein, only a portion of theconnections between the illustrated hardware blocks is generallydepicted. In addition, those skilled in the art will appreciate thatelectronic wireless hand held multimedia device 11 can be implemented asa specific type of a hand held mobile device, such as a Smartphone,Personal Digital Assistant (PDA), paging device, LTE-enabled mobilephone, and other associated hand held computing devices well known inthe art.

Mobile device 11 can be configured to permit images, such as broadcastedvideo images or other multimedia data, to be displayed on display 18 fora user to view. Electronic wireless hand held multimedia device 11 thusincludes an image-processing unit 35 for processing images transmittedas data to electronic wireless hand held multimedia device 11 throughwireless unit 17. A payment module 34 can be implemented in the device11 to enable the management of payment transactions which can benegotiated wirelessly through the device, for example, by enabling handheld device users to be billed a transaction fee via bank accounts(e.g., ATM, Debit and Credit cards) billing via communication serviceaccounts or arrangements, prepaid services, and other authorizedaccount-related billing arrangements. Payment can be made directly to awireless point of sale and/or over data networks. A security module canbe provided to enable protected data retrieval and management byenabling the use of passcodes, passwords, and/or biometrics andcommunications security during hand held device communications. A videocamera and video transmission capabilities enable a user to capture,store, process, and transmit video and take pictures. Payment module 34can be linked through internal bus 26 to CPU 10. Additionally, asecurity module 36 can be utilized to process proper security codes tothereby ensure data (e.g., multimedia data) transferred to and fromelectronic wireless hand held multimedia device 11 can be secured and/oraccess can be permitted. Security unit 36 can be implemented as anoptional feature of electronic wireless hand held multimedia device 11.Security unit 36 can also be configured with routines or subroutinesthat are processed by CPU 10, and which prevent wireless data from beingtransmitted/received from electronic wireless hand held multimediadevice 11 beyond a particular frequency range, outside of a particulargeographical area associated with a local wireless network, or absentauthorized authorization codes (e.g., decryption).

Those skilled in the art can appreciate that although a mobile device 11is generally illustrated in FIG. 1(a), other mobile devices can beimplemented as a wireless application protocol (WAP), web-enabledcellular hand held device, such as a PDA, wireless telephone, or acombination thereof. Mobile device 11 can be configured with features ofcombination cellular telephone/PDA devices. Mobile device can alsopermit users to access e-mail, store calendars, and contact databases.Mobile device 11 can also be configured to include the use of multi-RF(Radio Frequency) receiver-enabled hand held television viewing device.Regardless of the type of hand held device implemented, it can beexpected that such a hand held devices will be adapted to receive andprocess data via image-processing unit 35 for ultimate display as movingimages (video) on display 18, in accordance with the present invention.Image-processing unit 35 can include image-processing routines,subroutines, software modules, and so forth, which performimage-processing operations.

FIG. 2, labeled as prior art, illustrates a pictorial representation ofa mobile device 11, which can be utilized to implement a preferredembodiment. Mobile device 11 includes a display screen 18. Multimediadata (e.g., video, audio, graphics, etc.) broadcast via radio frequencyor provided digitally and wirelessly can be displayed on display screen18 for a user to view. User controls 32 can permit a user to manipulateimages or text displayed on display screen 18, such as the buttons on akeyboard provided on most Blackberry devices. A touch screen userinterface can be further configured on the display screen 18 with mobiledevice 11 to permit a user to manipulate images/text displayed ondisplay screen 18.

FIG. 3, labeled as prior art, depicts a pictorial representation ofmobile device 11 adapted for receiving a cartridge 50, in accordancewith an alternative embodiment. Mobile device 11 of FIG. 3 is generallyanalogous to mobile device 11 of FIG. 2, the difference being thatmobile device 11 of FIG. 3 can be adapted to receive a cartridge bearingsoftware and/or hardware modules (including memory) that permits mobiledevice 11 of FIG. 3 to function according to specific hardware and/orinstructions contained in a memory location within cartridge 50. Thealternative embodiment depicted in FIG. 3 thus represents a variation tothe embodiment illustrated in FIG. 2.

Cartridge 50 can be configured as a smart card of another appropriatemodule. Such a smart card can provide, for example, access codes (e.g.,decryption) to enable mobile device 11 to receive data broadcasts. Notethat as utilized herein, the term “module” can refer to a physicalmodule, such as a cartridge. The term “module” can also refer toelectronics and hardware stored on a cartridge. The term “module” canalso refer to a software module composed of routines or subroutines thatperform a particular function (e.g., an “App”). Those skilled in the artcan appreciate the meaning of the term module is based on the context inwhich the term is utilized. Thus, cartridge 50 can be generallyconfigured as a physical cartridge or smart card. The term “module” asutilized herein can also refer to a software module, depending on thecontext of the discussion thereof.

To illustrate the use of a physical module, such as module 50, assumethat a user can possess several such physical modules or cartridges. Acartridge, when inserted into mobile device illustrated in FIG. 3, caninstruct mobile device 11 to function as a standard smartphone, such asan iPhone or Samsung branded device. Other functions includingcommunications, software, memory, and supplemental circuitry can beprovided using a cartridge that can be inserted within and removed fromthe mobile device 11.

Those skilled in the art can thus appreciate that electronic wirelesshand held multimedia device 11 can be adapted to receive and cooperatewith cartridge 50. Additionally, mobile device 11 includes displayscreen 18, which can be similar to display unit 18 of FIG. 1. Electronicwireless hand held multimedia device 11 depicted in FIG. 3 can alsoinclude user controls 32. Thus, mobile device 11 can also implementtouch screen capabilities through a touch screen user interfaceintegrated with display screen 18.

Assuming cartridge 50 is implemented as a smart card, it is anticipatedthat similar features can be implemented in accordance with the smartcard to insure that hand held device 11 includes touch screen userinterface 18 and video viewing capabilities. Smart cards are generallyknown in the art as credit-card sized plastic cards with an embeddedcomputer chip. The chip can either be a microprocessor with internalmemory or a memory chip with non-programmable logic. The chip connectioncan be configured via direct physical contact or remotely through acontactless electromagnetic interface.

Smart cards can be generally configured as either a contact orcontactless smart card, or a combination thereof. A contact smart cardrequires insertion into a smart card reader (e.g., contained within handheld device 56) with a direct connection to, for example, a conductivemicromodule on the surface of the card. Such a micromodule can begenerally gold plated. Transmission of commands, data, and card statustakes place through such physical contact points.

A contactless card requires only close proximity to a reader. Both thereader and the card can be implemented with antenna means providing acontactless link that permits the devices to communicate with oneanother. Contactless cards can also maintain internal chip power or anelectromagnetic signal (e.g., RF tagging technology). Two additionalcategories of smart codes, well known in the art, which are based oncontact and contactless cards, are the so-called Combi cards and Hybridcards.

A Hybrid card generally can be equipped with two chips, each with arespective contact and contactless interface. The two chips are notconnected, but for many applications, this Hybrid serves the needs ofconsumers and card issuers. The Combi card can be generally based on asingle chip and can be generally configured with both a contact andcontactless interface.

Chips utilized in such smart cards are generally based on microprocessorchips or memory chips. Smart cards based on memory chips depend on thesecurity of the card reader for their processing and can be utilizedwith low to medium security requirements. A microprocessor chip can add,delete, and otherwise manipulate information in its memory.Microprocessor-based memory cards typically contain microprocessor chipswith a variety of architectures.

The mobile device 11 of FIGS. 1-3 can be configured as a hand heldwireless device adapted for use with a cartridge/module, such as module50. The cartridge/module 50 can contain the electronics (e.g., tuner,filter, etc.) to allow a hand held device to be adapted for receivingmultimedia data. Mobile device 11 includes a display screen 18 for thedisplay of multimedia data. Additionally, display screen 18 ofelectronic wireless hand held multimedia device 11 can be configuredwith a touch screen user interface displayable and operable on displayscreen 18. Display screen 18 can include one or more touch screen areas.

The following writing with respect to FIGS. 4-5 describes cancertreatment using neurocodes and is being provided only as an examplebioelectronic treatment. This example is not meant to be limiting innature and should not be interpreted as so. The present invention isapplicable to all forms of neurocode/bioelectronics treatment.

A cell is the smallest unit of life. Groups of cells make upmulti-cellular organisms. The human body is made up of some 100 trillioncells. Cells utilize electrical and chemical signaling in operatinginterior and exterior mechanisms depending on the composition of thecell. Some cells are operational and signal to the brain and receivesignals from the brain to regulate muscles, gland, and vital organs.Other cells only take instructions from the brain while organs andglands confine their cells to dedicated processes concerning themaintenance of life. Certain nerves and their cells are dedicated tosensing internal body status or seek information from outside the body,all with electrically encoded signals. The electrical cellular signalpattern of a malignant as well as a non-malignant cell must be able tobe detected, recorded, and it must be reprogrammable to accessoperational control of critical nucleous activity.

Cancer cells operating as an organized tumor structure do not conduct orexchange signaling processes with normal cells. They do, however,communicate with other cells within a given tumor. They focus on theirown interior signaling and metabolism while communicating with adjacentcancer cells. Cancer cells do not participate in any operationalfunctions within a human or animal body except among themselves. Cancercells do not aid or do anything beneficial for a human body. They areselfish and only live to reproduce and steal nutriment and oxygen fromthe body in which they reside.

Cancer cells, as they form a malignant tumor, require more blood flow.To accomplish this, they have evolved a way to signal to nearby arterialblood supplies so as to order-up the formation of buds on the arterythat ultimately extend into blood vessels that travel over to andpipeline into the tumor. With additional blood flow, the tumor continuesto reproduce and extend its dominance over its primary site.

Referring to FIG. 4, labeled as prior art, a cancer cell cluster ortumor is illustrated 60. By means of an imulus or other probe asdescribed by way of example in FIG. 5, the resident electrical signal orsignals of the cancer are then provided to a computer system 65 forstoring and processing. Typically, the computer system 65 is digital,and in order to accept the electrical signals from the tumor 60, ananalog to digital converter 62 is used. If the computer system 65employed includes an embedded analog to digital converter, the converter62 can be omitted. It is the computer system 65 in which all of theprocessing, analysis and generation of confounding electrical signalsoccurs. In order to treat the tumor 60, the confounding electricalsignals are applied directly to the tumor 60 via an imulus or probeafter conversion to analog state by a digital to analog converter 66.

The technical approach is to initially develop a number of cancer cellresident electrical signals for different species of cancer and perfectreprogrammed confounding type signals. The user then sorts andreprograms the natural signals of the cancer cell and tinkers with theelectrical signatures and coding to finally select appropriate treatmentelectrical signals, also known as confounding electrical signals. Thisis followed by devising a library/data-base of treatment signals. Thecollection of treatment signals may be cataloged as to the species ofcancer and anatomical location. During treatment of a cancer, the firststep is to identify the species of cancer and then select the properconfounding signal with which treatment will begin. Once the treatmentteam knows the species such as carcinoma or sarcoma, they select fromthe computerized library/data-base the most appropriate treatmentsignal. There are approximately about a total of 200 cancer species inexistence. Ultimately, the treatment library will be composed of atleast as many definitive cancer confounding, interclusio, or mortifiersignals. Carcinoma species is the most common cancer and likelyrepresents something like 50% of all cancerous tumors throughout thebody.

Once the cancer cell locations in a patient have been identified, thecancer cellular electrical activity has been recorded and analyzed, andan appropriate response has been determined, the medical staff candevelop and initiate a treatment protocol. The protocol will followestablished medical procedures with the main objective of applying theproper signals and appropriate electrical energy to the cancerous cellsto cause apoptosis. The computer system 60 can contain a low voltage andamperage power supply to ensure the correct voltage and amperage isdelivered to the cancerous cells. The electrical energy delivered isless than 1 volt and less than 10 millionths of an amp for a pulsedapplication on the cancer over a few seconds. The treatment may berepeated. The range of electrical treatment may span upwards of 2 voltsand 70 micro amps and as low as one-tenth of a volt or possibly evenlower at 2 microamps or even lower into the picoamp range. The treatmenttime may extend up to 4 minutes or more and is repeatable over days ifrequired. The treatment signals in the form of an electrical signal willhave a definable shape and be encoded to confound the natural electricalactivity found in the cancer cell plasma membrane wall and within thevery interior of the cell proper. With the use of the proper code toshut off cellular electricity, the result is apoptosis of the cancer.Cancer death can begin in less than an hour once its metabolic processesare shut-down. Cell death actually may occur in less than 10 minutes asa human brain cells do when blood circulation or electrical signals areturned off. Natural resuscitation of the cancer cell may be possible ifthe confounding electrical signal treatment is too brief or incomplete.Otherwise irreversible biological decay will set in as long as thecellular process has been severely damaged by the treatment signals. Thebody immune system is expected to consume the dead or dying cancer assoon as the outer cell membrane negative electric charge is off ormarkedly diminished. It is the strong negative outer electrical chargeof the cancer cell membrane glycocalyx that keeps the immune cells fromattacking since they too are negatively charged and would be repelledfrom one another. Normal cells have outer coat charges that are usuallypositive and are therefore accessible to the negatively charged immunesystem cells.

Treatment can be done with a small cable of total diameter no more thana wooden matchstick. Referring to FIG. 5, labeled as prior art, animulus or treatment contact unit 68 can be utilized to provide treatmentwithin a mammal body. The imulus can be provided in a small form factorand can contain hundreds or thousands of carbon nanotubes 69. Thenanotubes 69 may be hollow or partitioned. In addition they may becoated with a metal deposition or chemical that interferes with theglycocalyx strong negative electrical charge. The carbon nanotubesequipped imulus 68 can appear under a microscope like a hair brush. Eachnano fiber tube is about one-ten-thousandths of a human hair indiameter. The imulus 68 can be used to both record and apply thetreatment signal and may be of different sizes to fit the various cancerclusters. The physical approach to the cancer can be guided byfluoroscopy or other visualization apparatus or system to insure thatthe treatment is applied properly and completely and is directed at thecorrect target.

The imulus 68 can be positioned to make contact with the tumor as theprimary junction between the computer system 65 and the malignantcellular tumor 60, which is to be treated. Modified nano carbon tubescan also act like an antenna and only need to be in close proximity ofthe malignancy to send in the interclusio or impulses mortifier codes,Insertable links, implantable antennas, and contact pads or implacabletreatment needles of carbon or metal can be in the arsenal of imulusattachments, among others.

It has been preferred that analog computers are used because they are assensitive and able to record the cancer electrical signals as required.As analog computer developments advance they may be more suitable and bethe system of choice in destroying cancer cell life. Otherwise thesystem as illustrated, if digital, can utilize A-D and D-A converters62, 66, interfaced with a digital processor in the computer system 65using appropriate software to control signals for monitoring anddelivering treatment.

Examples of other processes that cells naturally perform viabioelectronics signals and which are relevant to neurocode treatmentare:

a. Cell reproduction

b. Encoding of proteins

c. Regulation of growth

d. Differentiation of the cell

e. Internal cell communication

f. External signaling to other cells

g. Excretion of chemicals

h. On or off control of secretions or excretions

i. Timing of operations for cellular organelles

j. Various levels of signaling within the nucleus

k. Signals between plasma membrane and nucleus

l. Operation of transport mechanisms in cell wall

Cell signaling is accomplished by a combination of electrical andchemical interactions. Different types of cells require a varied levelof signaling qualities. The creation or generation of a given cellssignals begins in the plasma membrane where raw material and chemicalions are taken in from the extracellular matrix to both generateelectricity and establish the signal format. The plasma membrane is asort-of cell wall and the area that takes in the required raw materialvia its ion channels. Ion channels open and close to allow passage intoand from the cell interior. Electrical signals are likely generated inthe plasma membrane before they are sent via the cytoskeleton, all aboutthe cell to go and participate and contribute to cell operations.

Referring to FIG. 6, illustrated is a block diagram of a mobile device100 similar to the mobile device 11 illustrated and described withrespect to FIGS. 1-3, but the mobile device 100 of FIG. 6 includes aneurocode module 110 therein. The mobile device 100 can also represent atablet computer having a neurocode treatment module 110 therein.

Referring to FIG. 7, illustrated is a block diagram of a mammalimplantable controller (MIC) 120, which is illustrated by example asbeing implanted in a mammal body 127. The MIC 120 can include amicroprocessor 121 for processing data and running applicationassociated with neurocode treatment, wireless module 122 supportingshort range wireless communications with treatment devices (e.g., mobiledevice 100) located outside the mammal body 127, memory 123 for storingdata and onboard applications (e.g., monitoring and therapyadministration functions), sensors 124 tied to monitoringbody/biological functions, a neurocode delivery module 125 (codespecific to monitoring conditions, secure communication, and deliveringtreatment), and electromagnetic charging hardware 126 (including powersupply) enabling the MIC 120 to remain functional and charged with powerwithout invading the mammal body 127 with wires or other apparatusesphysically entering the mammal body 127. The MIC 120 can be mostlysemiconductor-based and support short-range communications through themammal body 127 with mobile devices 100 as well as other devices (e.g.,facility communication pods described in FIG. 10) to providing datarepresenting conditions of the mammal body collected by sensors/probesalso located within the mammal body 127. The MIC can also receive andadminister treatment codes (neurocodes) received from outside the mammalbody (e.g., via mobile devices or facility communication pods).

Referring to FIG. 8, illustrated is a functional diagram of a mobiledevice 100 such as that in FIG. 6 in short-range wireless communicationwith at least one mammal implanted controller (MIC) 120 embedded in amammal body 127, such as presented in FIG. 7. FIG. 8 illustrates a basicconfiguration for wirelessly administering neurocode treatment tomammals via MICs 120.

Referring to FIG. 9, illustrated is a functional diagram of a mobiledevice 100 in communication with a remote neurocode treatment server 160via a data communication network 150. Mammal conditions (monitored orobtained externally) can be provided to the remote treatment server 160for analysis, and treatment neurocodes can be obtained/provided by thetreatment server 160 to the mobile device 100 for communication to atleast one MIC (as in FIG. 8) for treatment of a mammal.

Referring to FIG. 10, illustrated is a functional diagram of the mobiledevice 100 containing a neurocode treatment module 110 (as described inFIG. 6) in communication with a remote neurocode treatment server 160via a data communication network 150, and also in communication with amammal implanted controller 120. Monitored data obtained from the MIC120 by the mobile device 100, and/or provided to the mobile device bytreatment personnel, can be communicated wirelessly over data network150 to the remote treatment server 160. The data can be analyzed by theremote treatment server 160, and neurocodes can be feedback to themobile device from the treatment server 160, based on the analysis, forwireless transmission to the MIC 120, which can then administer theneurocodes as treatment to the mammal body (e.g., to an organ ortreatment area).

Referring to FIG. 11, illustrated is a functional diagram of a mobiledevice in communication with a MIC 120 and a remote treatment server160. Also shown in FIG. 11 is a resident treatment pod 170 including aneurocode treatment module integrated 175 therein. At least one residenttreatment pod 170 can be installed in a facility, such as a treatmentfacility or hospital, where a patient or patients undergoing neurocodetherapy is/are located. The resident treatment pod 170 can communicatewith the remote treatment server 160 via a data network 150 similarly tohow the mobile device 100 can. The resident treatment pod 170 can alsocommunicate wirelessly with MIC 120, which can be associated withpatients/guests to the facility. Monitored mammal conditions from theMIC 120 and treatment neurocodes provided to the MIC 120 foradministration to the mammal can be facilitated exclusively through theresident treatment pod 170, or as a backup or supplement to the mobiledevice 100. It can be appreciated that, in a facility such as ahospital, a treating physician can obtain monitored conditions from apatient's MIC 120 using a mobile device 100 (e.g., tablet computer usedby doctor on rounds in a hospital) and can provide the conditions asdata to a remote treating server 160 over the data network 150. Theserver can then analyze and provide treatment codes as feedback directlyto the patient via the resident treatment pod 170, or can provideanalysis to the physician via his mobile device 100 for furtherevaluation by the physician. A physician may determine that treatmentcodes are necessary based on analysis of the treatment server data andcan provide treatment codes directly to the MIC, or can order treatmentcodes at the treatment server for administration (either once or on atreatment schedule) for delivery to the MIC via a resident treatment pod170.

It should also be appreciated that resident treatment pods can bedistributed throughout a facility for tracking, monitoring, andtreatment of patients (e.g., such as residents roaming about in anursing home or patients being moved within a hospital). By doing this,patients are assured to continue monitoring and obtain neurocode-basedtreatments. Furthermore, the physician and facility can maintain atreatment log for the patient record, insurance purposes, and forbilling purposes.

FIGS. 12-14 illustrate flow diagrams for methods of monitoring andproviding neurocode based bioelectronic therapy to a mammal inaccordance with the teachings of the present contained herein. Referringto FIG. 12 a block diagram 200 for a method of treatment is illustrated.Referring to block 210, a MIC monitors a mammal's condition. Next, asshown in block 220, the mammal condition is wirelessly provided to atleast one of a mobile device 100 or a remote treatment server 160 fromthe MIC. The MIC then wirelessly receives at least one treatment codefrom at least one of the mobile device 100 or remote treatment server160 in response to the mammal condition (as monitored and reported bythe MIC), as shown in block 230. Then, as shown in block 240, the MICprovides treatment code to the mammal to adjust the previously monitoredand reported condition. The process can continue again as shown byfeedback loop 250.

As shown in the flow diagram 300 of FIG. 13, a mobile device is providedwith a mammal's condition, block 310. The condition can be provided fromany combination of MIC monitoring, from measurements of vital obtainedby a technician, or from external monitoring devices. Then as shown inblock 320, the mammal condition is analyzed by at least one of themobile device or a remote treatment server. It should be appreciatedthat some level of analysis can be provided at the mobile device, whilemore extensive analysis may require the computing and analysis resourcesof a remote treatment server. Then, as shown in block 330, a MIC iswirelessly provided a treatment code from at least one of the mobiledevice or a resident treatment pod in response to the analyzed mammalcondition. The MIC then provides the treatment code to the mammal toadjust the mammal's condition. The treatment can be administered via theMIC, a probe via the MIC to an organ, or treatment location in themammal.

Referring to FIG. 14, a block diagram of a treatment method 400 isillustrated. As shown in block 410, at least one of a mobile device orremote treatment server is provided with a mammal condition. As shown inblock 420, the mammal condition is evaluated by at least one of themobile device or the remote treatment server. Then as shown in block430, the MIC is wirelessly provided a treatment code from at least oneof the mobile device or the resident treatment pod in response to theanalyzed mammal condition. Finally, as shown in block 440, the MICprovides the treatment code to the mammal (e.g., organ or treatmentlocation) to adjust the condition.

The aforementioned description has thus been presented with respect topreferred and alternative embodiments of the present invention, whichcan be embodied in the context of a data-processing system such ascomputer system, in conjunction with program, and data-processing systemand network depicted in FIGS. 10 and 11. The disclosed embodiments,however, are not limited to any particular application or any particularenvironment. Instead, those skilled in the art will find that thesystems, methods and processor-readable media described herein may beadvantageously applied to a variety of system and application software,including database management systems, word processors, and the like.Moreover, the systems, methods, and processor-readable media disclosedherein may be embodied on a variety of different platforms, includingMacintosh. UNIX, LINUX, and the like. Therefore, the descriptions of theexemplary embodiments, which follow, are for purposes of illustrationand not considered a limitation of the disclosed embodiments.

It will be understood that the circuits and other means supported byeach block and combinations of blocks can be implemented by specialpurpose hardware, software, or firmware operating on special orgeneral-purpose data processors, or combinations thereof. It should alsobe noted that, in some alternative implementations, the operations notedin the blocks might occur out of the order noted in the figures. Forexample, two blocks shown in succession may, in fact, be executedsubstantially concurrently, or the blocks may sometimes be executed inthe reverse order.

The disclosed embodiments thus cover systems for monitoring mammal(animal and human) biological/health conditions, recording conditions,and providing feedback in the form of a neurocodes (e.g., bioelectronicssignals, electroceutical signals, low voltage frequencies) stored in amemory and associated with a treatment based on the monitored condition.The neurocodes can be recorded, stored, and transmittable from thecomputer, which can be stationary or handheld, wired or wireless. Mammalbiological condition can be monitored by at least one mammal implantablecontroller including a wireless transceiver for supportingbi-directional communication with the computer. Wireless communicationcan be secured by encryption between the computer and implantablecontroller and can utilize short-range wireless communications protocols(e.g., Bluetooth, Bluetooth LE, Near Field Communication (NFC), RadioFrequency Identification (RFID), etc.).

Computer generated analog treatment signal(s), which are aimed at thecellular nucleus, are transmitted through the plasma membrane or its ionchannel pathways. Signals would travel directly through thephosphor-lipid bilayer and through the internal membrane surface so asto enter the cellular interior. The treatment signals may travel on theintermediate and/or microfilaments located in the cancer cellularinterior to reach the nucleus.

The use of the hybrid scientific computer described in other issuedpatents of the inventor is also available to use in addition to thepresent invention herein described. Said neuro-electric inventionrecords the intrinsic electrical signals found in cancer cells and thenreprograms such signals. Re-transmitting such reprogrammed treatmentsignals can be applied anywhere in or on the human or animal bodydepending on the size and location of the tumor to be treated.

Methods and systems are thus disclosed for the rapid destruction ofcancer tumor(s) that are made up of thousands to millions of livingmalignant cancer cells. This approach seeks to kill said tumor(s) bycausing apoptosis or excitotoxicity and/or osmotic-shock within a humanor animal for medical treatment.

Conventional targeted cancer therapies are drugs or other substancesthat block the growth and spread of cancer by interfering with specificmolecules involved in tumor growth and spreading or engaging inmetastatic colonization throughout the body. The disclosed embodiments,on the other hand, can implement a technology that kills the livingcancer cells directly and quickly leaving only dead cancer cells.

The disclosed embodiments can accomplish treatment during a time from,for example, up to 20 minutes, or up to multiple hours, against atargeted cancer located in a human or animal. Eukaryote living tissue.All malignant species are eligible for such treatment. Eukaryoteclassification consists of cellular organisms whose individual cellcontains a nucleus and other organelles enclosed within membranes. Thedead tumors are removable from live patients, leaving no live cancercells.

It will be appreciated that variations of the above-disclosed and otherfeatures and functions, or alternatives thereof, may be desirablycombined into many other different systems or applications. Also, thatvarious presently unforeseen or unanticipated alternatives,modifications, variations or improvements therein may be subsequentlymade by those skilled in the art which are also intended to beencompassed by the following claims.

What is claimed is:
 1. A system for treating mammals with neurocodes tocause at least one of a change in a biological function of an organ ortrigger cell death in cancer cells, said system comprising: a mammalimplanted controller (MIC) implantable within a mammal to monitorbioelectronic signals indicating a health condition of the mammal, saidMIC further including a probe connectable to a target organ or a regionwithin the mammal and associated with at least one of: a sensor, aneurocode treatment module, and a wireless communication module; atleast one of: a mobile device and a resident treatment pod external toand associated with the mammal and adapted to communicate wirelesslywith the MIC; a remote server adapted to receive recorded datarepresenting the bioelectronics signals from the MIC over a digital datacommunication network from at least one of the mobile device and theresident treatment pod associated with the mammal and communicating withthe MIC; wherein the remote server evaluates the bioelectronics signalsand in response provides neurocoded treatment signals to cause at leastone of a change in a biological function of an organ or trigger celldeath in cancer cells through at least one of the mobile device and theresident treatment pod for further transmission to the MIC, whereinmammal conditions are treated via administration of the neurocodedtreatment signals to the mammal to cause at least one of the change inthe biological function of the organ or triggering cell death in cancercells by the MIC and the MIC and remote server engage in ongoinganalysis of the bioelectronics signals and treatment based on theongoing analysis.
 2. The system of claim 1, wherein the mobile deviceincludes a smartphone carried by the mammal and a neurocode treatmentmodule, and a wireless communications module supporting short-range datacommunications with the MIC and communications with the remote servervia a data network to obtain periodic remote analysis and access toneurocodes for application as treatment to the mammal based on theanalysis.
 3. The system of claim 2, wherein the resident treatment podincludes an electronic device associated with an environment containingthe mammal and a neurocode treatment module and a wirelesscommunications module supporting short-range data communication with theMIC and data network communications with the remote server via a datanetwork to obtain periodic remote analysis and access to neurocodes forapplication as treatment to the mammal based on the analysis.
 4. Thesystem of claim 1, wherein the resident treatment pod includes anelectronic device associated with an environment containing the mammaland a neurocode treatment module and a wireless communications modulesupporting short-range data communication with the MIC and data networkcommunications with the remote server via a data network to obtainperiodic remote analysis and access to neurocodes for application astreatment to the mammal based on the analysis.
 5. The system of claim 1,wherein said resident treatment pod is installed within a treatmentfacility, a hospital or a private residence in association with aspecific patient.
 6. The system of claim 1, wherein said MIC includes anelectromagnetic charging module and a rechargeable power supply.
 7. Thesystem of claim 1, wherein said mobile device comprises at least one ofa smartphone or a tablet computer.
 8. A method for providing a neurocodetreatment to mammals, said method comprising: obtaining realtimemonitoring of a mammal condition in the form of a bioelectronic signalby a MIC implanted in a mammal utilizing wireless communications to atleast one of a mobile device and a resident treatment pod provided inassociation with the mammal; providing recordings of the bioelectronicsignal representing realtime monitoring from the at least one of themobile device and the resident treatment pod to a remote treatmentserver via a data communications network for analysis of the mammalcondition represented by the bioelectronics signal; providing the atleast one of the mobile device and the resident treatment pod withtreatment updates in the form of neurocodes from the remote treatmentserver over the data communications network for local wirelesstransmission to the MIC from the at least one of the mobile device andthe resident treatment pod for application to the mammal in the form ofat least one neurocode for administration to the mammal from the MICbased on the analysis by the remote server; and providing neurocodes astreatment from the MIC as feedback in response to the realtimemonitoring and remote treatment server analysis, wherein the treatmentis provided to cause at least one of a change in biological function ofan organ or trigger cell death in cancer cells.
 9. The method of claim8, wherein the MIC continues monitoring the mammal for condition changesand reports changes in condition to at least one of the mobile device,the resident treatment pod, and the remote treatment server when changeis detected to obtain feedback treatment in the form of neurocodes. 10.A method for providing neurocode treatment to mammals to cause at leastone of a change in biological function of an organ or trigger cell deathin cancer cells, said method comprising: monitoring a mammal conditionin realtime with a smartphone as a mobile device carried by the mammaland obtained from at least one of a MIC implantable in the mammal by thesmartphone via short-range wireless communications, wherein the MIC isfurther connected to an organ or cell region of interest by a probe;providing recordings of realtime monitoring of the mammal condition fromat least one of the organ or the cell region as provided from the MICand from the smartphone to a remote treatment server over a wirelessdata communications network for analysis; receiving treatment updates inthe form of neurocodes from the remote treatment server at thesmartphone over the wireless data communications network for provisionto the MIC via short range wireless data communications in the form ofupdated neurocodes from mobile device for administration to the mammalas treatment to cause at least one of a change in biological function ofan organ or trigger cell death in cancer cells; and administering thetreatment to cause at least one of a change in biological function of anorgan or trigger cell death in cancer cells in the form of updatedneurocodes to the mammal from the MIC in the form of bioelectronicsignals representing the nuerocodes provided by the remote treatmentserver.
 11. The method of claim 10, wherein the MIC and the smartphonecontinuously monitor the mammal for condition changes and reportscondition changes to the remote server for analysis and to obtaintreatment to cause at least one of a change in biological function of anorgan or trigger cell death in cancer cells in the form of neurocodes.